The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global General Anesthetic for Surgery Market Research Report 2024
Synopsis
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
Global General Anesthetic for Surgery market is projected to reach US$ 4983.4 million in 2029, increasing from US$ 3926 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole General Anesthetic for Surgery market research.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global General Anesthetic for Surgery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The General Anesthetic for Surgery report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
Global General Anesthetic for Surgery market is projected to reach US$ 4983.4 million in 2029, increasing from US$ 3926 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole General Anesthetic for Surgery market research.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global General Anesthetic for Surgery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The General Anesthetic for Surgery report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 General Anesthetic for Surgery Market Overview
1.1 Product Overview and Scope of General Anesthetic for Surgery
1.2 General Anesthetic for Surgery Segment by Type
1.2.1 Global General Anesthetic for Surgery Market Value Comparison by Type (2023-2029)
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Remifentanil
1.2.5 Etomidate
1.2.6 Isoflurane
1.2.7 Other
1.3 General Anesthetic for Surgery Segment by Application
1.3.1 Global General Anesthetic for Surgery Market Value by Application: (2023-2029)
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Global General Anesthetic for Surgery Market Size Estimates and Forecasts
1.4.1 Global General Anesthetic for Surgery Revenue 2018-2029
1.4.2 Global General Anesthetic for Surgery Sales 2018-2029
1.4.3 Global General Anesthetic for Surgery Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 General Anesthetic for Surgery Market Competition by Manufacturers
2.1 Global General Anesthetic for Surgery Sales Market Share by Manufacturers (2018-2023)
2.2 Global General Anesthetic for Surgery Revenue Market Share by Manufacturers (2018-2023)
2.3 Global General Anesthetic for Surgery Average Price by Manufacturers (2018-2023)
2.4 Global General Anesthetic for Surgery Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of General Anesthetic for Surgery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of General Anesthetic for Surgery, Product Type & Application
2.7 General Anesthetic for Surgery Market Competitive Situation and Trends
2.7.1 General Anesthetic for Surgery Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest General Anesthetic for Surgery Players Market Share by Revenue
2.7.3 Global General Anesthetic for Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 General Anesthetic for Surgery Retrospective Market Scenario by Region
3.1 Global General Anesthetic for Surgery Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global General Anesthetic for Surgery Global General Anesthetic for Surgery Sales by Region: 2018-2029
3.2.1 Global General Anesthetic for Surgery Sales by Region: 2018-2023
3.2.2 Global General Anesthetic for Surgery Sales by Region: 2024-2029
3.3 Global General Anesthetic for Surgery Global General Anesthetic for Surgery Revenue by Region: 2018-2029
3.3.1 Global General Anesthetic for Surgery Revenue by Region: 2018-2023
3.3.2 Global General Anesthetic for Surgery Revenue by Region: 2024-2029
3.4 North America General Anesthetic for Surgery Market Facts & Figures by Country
3.4.1 North America General Anesthetic for Surgery Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America General Anesthetic for Surgery Sales by Country (2018-2029)
3.4.3 North America General Anesthetic for Surgery Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe General Anesthetic for Surgery Market Facts & Figures by Country
3.5.1 Europe General Anesthetic for Surgery Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe General Anesthetic for Surgery Sales by Country (2018-2029)
3.5.3 Europe General Anesthetic for Surgery Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific General Anesthetic for Surgery Market Facts & Figures by Country
3.6.1 Asia Pacific General Anesthetic for Surgery Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific General Anesthetic for Surgery Sales by Country (2018-2029)
3.6.3 Asia Pacific General Anesthetic for Surgery Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America General Anesthetic for Surgery Market Facts & Figures by Country
3.7.1 Latin America General Anesthetic for Surgery Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America General Anesthetic for Surgery Sales by Country (2018-2029)
3.7.3 Latin America General Anesthetic for Surgery Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa General Anesthetic for Surgery Market Facts & Figures by Country
3.8.1 Middle East and Africa General Anesthetic for Surgery Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa General Anesthetic for Surgery Sales by Country (2018-2029)
3.8.3 Middle East and Africa General Anesthetic for Surgery Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global General Anesthetic for Surgery Sales by Type (2018-2029)
4.1.1 Global General Anesthetic for Surgery Sales by Type (2018-2023)
4.1.2 Global General Anesthetic for Surgery Sales by Type (2024-2029)
4.1.3 Global General Anesthetic for Surgery Sales Market Share by Type (2018-2029)
4.2 Global General Anesthetic for Surgery Revenue by Type (2018-2029)
4.2.1 Global General Anesthetic for Surgery Revenue by Type (2018-2023)
4.2.2 Global General Anesthetic for Surgery Revenue by Type (2024-2029)
4.2.3 Global General Anesthetic for Surgery Revenue Market Share by Type (2018-2029)
4.3 Global General Anesthetic for Surgery Price by Type (2018-2029)
5 Segment by Application
5.1 Global General Anesthetic for Surgery Sales by Application (2018-2029)
5.1.1 Global General Anesthetic for Surgery Sales by Application (2018-2023)
5.1.2 Global General Anesthetic for Surgery Sales by Application (2024-2029)
5.1.3 Global General Anesthetic for Surgery Sales Market Share by Application (2018-2029)
5.2 Global General Anesthetic for Surgery Revenue by Application (2018-2029)
5.2.1 Global General Anesthetic for Surgery Revenue by Application (2018-2023)
5.2.2 Global General Anesthetic for Surgery Revenue by Application (2024-2029)
5.2.3 Global General Anesthetic for Surgery Revenue Market Share by Application (2018-2029)
5.3 Global General Anesthetic for Surgery Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aspen Pharma
6.1.1 Aspen Pharma Corporation Information
6.1.2 Aspen Pharma Description and Business Overview
6.1.3 Aspen Pharma General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aspen Pharma General Anesthetic for Surgery Product Portfolio
6.1.5 Aspen Pharma Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Corporation Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Fresenius-Kabi General Anesthetic for Surgery Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AbbVie General Anesthetic for Surgery Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Corporation Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter Healthcare General Anesthetic for Surgery Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B.Braun
6.5.1 B.Braun Corporation Information
6.5.2 B.Braun Description and Business Overview
6.5.3 B.Braun General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B.Braun General Anesthetic for Surgery Product Portfolio
6.5.5 B.Braun Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Corporation Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Maruishi General Anesthetic for Surgery Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.6.1 Piramal Corporation Information
6.6.2 Piramal Description and Business Overview
6.6.3 Piramal General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Piramal General Anesthetic for Surgery Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Yichang Humanwell
6.9.1 Yichang Humanwell Corporation Information
6.9.2 Yichang Humanwell Description and Business Overview
6.9.3 Yichang Humanwell General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Yichang Humanwell General Anesthetic for Surgery Product Portfolio
6.9.5 Yichang Humanwell Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Corporation Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nhwa General Anesthetic for Surgery Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Corporation Information
6.11.2 Hengrui General Anesthetic for Surgery Description and Business Overview
6.11.3 Hengrui General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hengrui General Anesthetic for Surgery Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Xi'an Libang
6.12.1 Xi'an Libang Corporation Information
6.12.2 Xi'an Libang General Anesthetic for Surgery Description and Business Overview
6.12.3 Xi'an Libang General Anesthetic for Surgery Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Xi'an Libang General Anesthetic for Surgery Product Portfolio
6.12.5 Xi'an Libang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 General Anesthetic for Surgery Industry Chain Analysis
7.2 General Anesthetic for Surgery Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 General Anesthetic for Surgery Production Mode & Process
7.4 General Anesthetic for Surgery Sales and Marketing
7.4.1 General Anesthetic for Surgery Sales Channels
7.4.2 General Anesthetic for Surgery Distributors
7.5 General Anesthetic for Surgery Customers
8 General Anesthetic for Surgery Market Dynamics
8.1 General Anesthetic for Surgery Industry Trends
8.2 General Anesthetic for Surgery Market Drivers
8.3 General Anesthetic for Surgery Market Challenges
8.4 General Anesthetic for Surgery Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
